← Open Payments lookup

KRISTINA MULLEN: Open Payments

NPI 1124505706 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$751 in 32 payments from 10 companies in 2025. Trend: 2023 $2,234 · 2024 $1,883 · 2025 $751

Food & beverage: $751
CompanyPaymentsAmount
ABBVIE INC.15$272
Neurocrine BioSciences, Inc.3$174
Takeda Pharmaceuticals U.S.A., Inc.3$67
Otsuka America Pharmaceutical, Inc.3$66
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$43
Vanda Pharmaceuticals Inc.2$36
Lundbeck LLC1$34
E.R. Squibb & Sons, L.L.C.1$24
Teva Pharmaceuticals USA, Inc.1$20
Almatica Pharma LLC1$15

Products named: VRAYLAR, INGREZZA, REXULTI, TRINTELLIX, CAPLYTA, FANAPT, COBENFY, AUSTEDO XR.

Industry payments across NC — which companies pay providers there.